{
    "nctId": "NCT00930579",
    "briefTitle": "Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation",
    "officialTitle": "Phase II Pre-Surgical Intervention Study for Evaluating the Effect of Metformin on Breast Cancer Proliferation",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 35,
    "primaryOutcomeMeasure": "Tumor Proliferation in Tumor Specimens",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically-confirmed operable invasive breast cancer or ductal carcinoma in situ (DCIS) who undergo core needle biopsy followed by surgical excision at least 2 weeks after enrollment\n* Body mass index \\> 25\n* Age \u2265 21 years\n* No prior chemotherapy, radiation therapy, or surgery within 6 months of study entry\n* Signed informed consent\n\nExclusion Criteria:\n\n* History of diabetes mellitus requiring medical therapy\n* Treatment with other investigational drugs within 6 months of study entry\n* Significant renal impairment with a creatinine \\> 1.4 mg/dl\n* Other serious intercurrent medical illness",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}